Intelligent Medicine

Publisher: Chinese Medical Association
Country: China · Asiatic Region
Type: journal
ISSN: 20969376

26671026

Scopus 1,349 SJR

Scopus Q1 SJR Q

WoS Q1 JCR Q

WoS 7,8 JIF

Scopus 18 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

SJR 1,349
Quartile Q1
H-Index 18
Cites/doc 8,75
Docs (3y) 92
Cites (3y) 818

Clarivate

Web of Science · JCR · 2025

JCR Q Q1
JIF 7,8
5Y JIF 7
JCI 0,95

WoS indexes

ESCI

Subject classification

Categories (SJR)

Artificial Intelligence Q1
Biomedical Engineering Q1
Health Informatics Q1
Medicine (miscellaneous) Q1

Areas

Computer Science
Engineering
Medicine

WoS categories

Computer Science, Interdisciplinary Applications | Medical Informatics

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q1	Q1	1,349	7,8	7	0,95	Q2	18
2024	Q1	Q1	1,075	6,9	6,1	0,85	Q2	14
2023	Q2	Q1	0,674	4,4	4,7	0,6	Q3	14
2022	Q3	—	0,289	—	—	—	—	14
2021	—	—	—	—	—	—	—	14

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year	Category	Edition	JCR Q (1997+)	JCI Q (1997+)	Rank
2025	COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS	ESCI	Q1	Q2	25/185
2025	MEDICAL INFORMATICS	ESCI	Q1	Q2	5/54
2024	COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS	ESCI	Q1	Q2	22/177
2024	MEDICAL INFORMATICS	ESCI	Q1	Q3	5/48
2023	COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS	ESCI	Q1	Q3	38/170
2023	MEDICAL INFORMATICS	ESCI	Q2	Q3	12/44